<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1118" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1118/" /><meta name="ncbi_pagename" content="IPEX Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>IPEX Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="IPEX Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/07/19" /><meta name="citation_author" content="Queenie K-G Tan" /><meta name="citation_author" content="Raymond J Louie" /><meta name="citation_author" content="John W Sleasman" /><meta name="citation_pmid" content="20301297" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1118/" /><meta name="citation_keywords" content="Immunodeficiency, Polyendocrinopathy, and Enteropathy X-Linked Syndrome" /><meta name="citation_keywords" content="Immunodeficiency, Polyendocrinopathy, and Enteropathy X-Linked Syndrome" /><meta name="citation_keywords" content="Forkhead box protein P3" /><meta name="citation_keywords" content="FOXP3" /><meta name="citation_keywords" content="IPEX Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="IPEX Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Queenie K-G Tan" /><meta name="DC.Contributor" content="Raymond J Louie" /><meta name="DC.Contributor" content="John W Sleasman" /><meta name="DC.Date" content="2018/07/19" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1118/" /><meta name="description" content="IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome is characterized by systemic autoimmunity, typically beginning in the first year of life. Presentation is most commonly the clinical triad of watery diarrhea, endocrinopathy (most commonly insulin-dependent diabetes mellitus), and eczematous dermatitis. Most children have other autoimmune phenomena including cytopenias, autoimmune hepatitis, or nephropathy; lymphadenopathy, splenomegaly, alopecia, arthritis, and lung disease related to immune dysregulation have all been observed. Fetal presentation of IPEX includes hydrops, echogenic bowel, skin desquamation, IUGR, and fetal akinesia. Without aggressive immunosuppression or bone marrow transplantation, the majority of affected males die within the first one to two years of life from metabolic derangements, severe malabsorption, or sepsis; a few with a milder phenotype have survived into the second or third decade of life." /><meta name="og:title" content="IPEX Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome is characterized by systemic autoimmunity, typically beginning in the first year of life. Presentation is most commonly the clinical triad of watery diarrhea, endocrinopathy (most commonly insulin-dependent diabetes mellitus), and eczematous dermatitis. Most children have other autoimmune phenomena including cytopenias, autoimmune hepatitis, or nephropathy; lymphadenopathy, splenomegaly, alopecia, arthritis, and lung disease related to immune dysregulation have all been observed. Fetal presentation of IPEX includes hydrops, echogenic bowel, skin desquamation, IUGR, and fetal akinesia. Without aggressive immunosuppression or bone marrow transplantation, the majority of affected males die within the first one to two years of life from metabolic derangements, severe malabsorption, or sepsis; a few with a milder phenotype have survived into the second or third decade of life." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1118/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ipex/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1118/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CD11AE0401721000000000653022F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1118_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1118_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/insr-ir/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/vws/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1118_"><span class="title" itemprop="name">IPEX Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Immunodeficiency, Polyendocrinopathy, and Enteropathy X-Linked Syndrome</div><p class="contrib-group"><span itemprop="author">Queenie K-G Tan</span>, MD, PhD, <span itemprop="author">Raymond J Louie</span>, PhD, and <span itemprop="author">John W Sleasman</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1118_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1118_ai__"><div class="contrib half_rhythm"><span itemprop="author">Queenie K-G Tan</span>, MD, PhD<div class="affiliation small">Duke University Medical Center<br />Durham, North Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ekud@nat.noohk" class="oemail">ude.ekud@nat.noohk</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Raymond J Louie</span>, PhD<div class="affiliation small">Greenwood Genetic Center<br />Greenwood, South Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cgg@eiuolr" class="oemail">gro.cgg@eiuolr</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">John W Sleasman</span>, MD<div class="affiliation small">Duke University Medical Center<br />Durham, North Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ekud@namsaels.nhoj" class="oemail">ude.ekud@namsaels.nhoj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 19, 2004</span>; Last Update: <span itemprop="dateModified">July 19, 2018</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ipex.Summary" itemprop="description"><h2 id="_ipex_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>IPEX (<i>i</i>mmune dysregulation, <i>p</i>olyendocrinopathy, <i>e</i>nteropathy, <i>X</i>-linked) syndrome is characterized by systemic autoimmunity, typically beginning in the first year of life. Presentation is most commonly the clinical triad of watery diarrhea, endocrinopathy (most commonly insulin-dependent diabetes mellitus), and eczematous dermatitis. Most children have other autoimmune phenomena including cytopenias, autoimmune hepatitis, or nephropathy; lymphadenopathy, splenomegaly, alopecia, arthritis, and lung disease related to immune dysregulation have all been observed. Fetal presentation of IPEX includes hydrops, echogenic bowel, skin desquamation, IUGR, and fetal akinesia. Without aggressive immunosuppression or bone marrow transplantation, the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males die within the first one to two years of life from metabolic derangements, severe malabsorption, or sepsis; a few with a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have survived into the second or third decade of life.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis is established in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FOXP3</i>. Affected females have not been reported; female carriers of a pathogenic variant do not have clinical findings.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Bone marrow transplantation (BMT) offers the only potential cure for IPEX syndrome. When done at the time of no or mild organ impairment, there is improved resolution of autoimmunity, especially when compared with non-transplanted individuals under chronic immunosuppressive therapy. T cell-directed immune suppression (i.e., sirolimus, cyclosporin A, or tacrolimus), either alone or in combination with steroids, is considered first-line therapy; granulocyte colony stimulating factor (G-CSF) for autoimmune neutropenia; rituximab for pemphigus nodularis and other autoantibody-mediated disease; nutritional support; standard treatment of diabetes mellitus and autoimmune thyroid disease; topical therapies for dermatitis.</p><p><i>Prevention of secondary complications</i>: Prophylactic antibiotic therapy for those with autoimmune neutropenia or recurrent infections; aggressive management of dermatitis with topical steroids and anti-inflammatory agents to prevent infection.</p><p><i>Surveillance</i>: Monitoring with lab tests for evidence of autoimmune disease every 3-6 months; frequent monitoring of growth parameters, nutritional intake, and stooling patterns; monitor for drug side effects if under immunosuppression related to bone marrow transplantation.</p><p><i>Evaluation of relatives at risk</i>: If the family-specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is known, <i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> in at-risk males immediately after birth to permit early diagnosis and BMT before significant organ damage occurs; otherwise, monitoring of at-risk males for symptoms to enable early diagnosis and treatment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>IPEX syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. The risk to sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the mother. If the mother of the proband is a carrier, the chance of transmitting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant are carriers and will not be affected. Affected males pass the pathogenic variant to all of their daughters and none of their sons. Carrier testing for at-risk relatives, prenatal testing for pregnancies at risk, and preimplantation diagnosis are possible for families in which the pathogenic variant has been identified.</p></div></div><div id="ipex.Diagnosis"><h2 id="_ipex_Diagnosis_">Diagnosis</h2><p>The term "IPEX" is an acronym for <i>i</i>mmune dysregulation, <i>p</i>olyendocrinopathy, <i>e</i>nteropathy, <i>X</i>-linked.</p><div id="ipex.Suggestive_Findings"><h3>Suggestive Findings</h3><p>IPEX syndrome <b>should be suspected</b> in males with the following clinical triad, family history, and suggestive laboratory findings.</p><p><b>Clinical triad</b></p><ul><li class="half_rhythm"><div><b>Enteropathy</b> that manifests as chronic watery diarrhea. Onset is typically in the first months of life; villous atrophy with a mononuclear cell infiltrate (activated T cells) in the lamina propria is the most common finding in biopsy.</div></li><li class="half_rhythm"><div><b>Endocrinopathy,</b> most commonly type 1 diabetes mellitus with onset in the first months or years of life. Autoimmune thyroid disease leading to hypothyroidism or hyperthyroidism has also been observed [<a class="bk_pop" href="#ipex.REF.wildin.2002.537">Wildin et al 2002</a>, <a class="bk_pop" href="#ipex.REF.gambineri.2003.430">Gambineri et al 2003</a>].</div></li><li class="half_rhythm"><div><b>Dermatitis,</b> most commonly eczematous presenting within the first months of life, although prenatal skin desquamation has been reported [<a class="bk_pop" href="#ipex.REF.louie.2017.1219">Louie et al 2017</a>]. Erythroderma, exfoliative dermatitis, psoriasis-like lesions, and pemphigus nodularis have also been observed [<a class="bk_pop" href="#ipex.REF.nieves.2004.466">Nieves et al 2004</a>, <a class="bk_pop" href="#ipex.REF.mcginness.2006.143">McGinness et al 2006</a>].</div></li></ul><p><b>Family history</b></p><ul><li class="half_rhythm"><div>Consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance</div></li><li class="half_rhythm"><div>Note: Lack of a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance does not preclude the diagnosis.</div></li></ul><p><b>Suggestive laboratory findings.</b> No laboratory findings specifically identify <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Evidence of <b>immune dysregulation</b> manifested by the following is suggestive of IPEX syndrome:</p><ul><li class="half_rhythm"><div>Elevated serum concentration of IgE (immunoglobulin E) and in some cases, IgA</div></li><li class="half_rhythm"><div>Eosinophilia</div></li><li class="half_rhythm"><div>Autoimmune anemia, thrombocytopenia, and/or neutropenia</div></li><li class="half_rhythm"><div>Autoantibodies to pancreatic islet antigens, thyroid antigens, small bowel mucosa, and other autoantigens</div></li><li class="half_rhythm"><div>Decreased numbers of FOXP3-expressing T cells in peripheral blood determined by flow cytometry &#x02013; although FOXP3 levels in regulatory T cells (Treg) can be normal in some cases</div></li></ul></div><div id="ipex.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of IPEX syndrome <b>is established</b> in a male proband with the typical clinical findings and by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FOXP3</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1118/table/ipex.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figipexTmoleculargenetictestingusedin" rid-ob="figobipexTmoleculargenetictestingusedin">Table 1</a>).</p><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected females have not been reported. Carrier status is determined by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FOXP3</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1118/table/ipex.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figipexTmoleculargenetictestingusedin" rid-ob="figobipexTmoleculargenetictestingusedin">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of IPEX syndrome is broad, individuals with the distinctive findings described in <a href="#ipex.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#ipex.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited disorders with enteropathy, endocrinopathy, and/or immune dysregulation or those in whom the diagnosis of IPEX syndrome has not been considered are more likely to be diagnosed using genomic testing (see <a href="#ipex.Option_2">Option 2</a>).</p><div id="ipex.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of IPEX syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>FOXP3</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm">Note: (1) Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>. (2) Disease-associated variants have been reported in the 5'UTR (c.-7G&#x0003e;T) and the 3'UTR (c.*876A&#x0003e;G and c.*876A&#x0003e;G). Since the 3'UTR variants are further 3' than typically included in sequencing assays, the assay design may need to be modified to include these variants.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>FOXP3</i> and other genes of interest (see <a href="#ipex.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="ipex.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by enteropathy, endocrinopathy, or immune dysregulation or when the diagnosis of IPEX syndrome is not considered because an individual has atypical phenotypic features, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="ipex.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in IPEX Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1118/table/ipex.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ipex.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ipex.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ipex.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_ipex.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_ipex.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FOXP3</i></td><td headers="hd_h_ipex.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,4</sup></td><td headers="hd_h_ipex.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%</td></tr><tr><td headers="hd_h_ipex.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_ipex.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 reported <sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ipex.TF.1.1"><p class="no_margin">See <a href="/books/NBK1118/#ipex.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ipex.TF.1.2"><p class="no_margin">See <a href="#ipex.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ipex.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="ipex.TF.1.4"><p class="no_margin">Lack of amplification by PCRs prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one or more exons or the entire <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a male; confirmation may require additional testing by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="ipex.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="ipex.TF.1.6"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the noncoding <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 has been reported [<a class="bk_pop" href="#ipex.REF.torgerson.2007.1705">Torgerson et al 2007</a>]; however, no systematic data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div></div><div id="ipex.Clinical_Characteristics"><h2 id="_ipex_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ipex.Clinical_Description"><h3>Clinical Description</h3><div id="ipex.Males"><h4>Males</h4><p>IPEX syndrome is generally considered to be a syndrome of neonatal enteropathy [<a class="bk_pop" href="#ipex.REF.ruemmele.2004.587">Ruemmele et al 2004</a>] and neonatal polyendocrinopathy [<a class="bk_pop" href="#ipex.REF.dotta.2002.283">Dotta &#x00026; Vendrame 2002</a>] found in males.</p><p><b>Presentation.</b> The most common presentation of IPEX syndrome is severe watery diarrhea, type 1 insulin-dependent diabetes mellitus, thyroiditis, and dermatitis in males younger than age one year. This disorder is frequently accompanied by other autoimmune phenomena.</p><ul><li class="half_rhythm"><div>Males with a somewhat milder/atypical disease <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can present at older ages [<a class="bk_pop" href="#ipex.REF.ge.2017.267">Ge et al 2017</a>, <a class="bk_pop" href="#ipex.REF.hwang.2018.388">Hwang et al 2018</a>].</div></li><li class="half_rhythm"><div>Fetal presentation of IPEX includes hydrops, echogenic bowel, skin desquamation, IUGR, and fetal akinesia. There may be a family history of pregnancy loss [<a class="bk_pop" href="#ipex.REF.rae.2015.284">Rae et al 2015</a>, <a class="bk_pop" href="#ipex.REF.vasiljevic.2015.2120">Vasiljevic et al 2015</a>, <a class="bk_pop" href="#ipex.REF.xavierdasilva.2015.131">Xavier-da-Silva et al 2015</a>, <a class="bk_pop" href="#ipex.REF.reichert.2016.226">Reichert et al 2016</a>, <a class="bk_pop" href="#ipex.REF.louie.2017.1219">Louie et al 2017</a>, <a class="bk_pop" href="#ipex.REF.shehab.2017.1040">Shehab et al 2017</a>].</div></li></ul><p><b>Enteropathy.</b> The enteropathy of IPEX syndrome, often the first sign, is present in virtually all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Even in those with milder disease, the diarrhea typically begins in the first six to12 months of life. Watery diarrhea, which may at times also have mucus and blood, leads to malabsorption, failure to thrive, and cachexia, often requiring the use of total parenteral nutrition (TPN) [<a class="bk_pop" href="#ipex.REF.bacchetta.2018.5">Bacchetta et al 2018</a>]. Exocrine pancreatic insufficiency has been observed in some cases [<a class="bk_pop" href="#ipex.REF.gambineri.2008.1105">Gambineri et al 2008</a>, <a class="bk_pop" href="#ipex.REF.scaillon.2009.368">Scaillon et al 2009</a>], which may worsen the diarrhea. Other gastrointestinal manifestations include colitis [<a class="bk_pop" href="#ipex.REF.lucas.2007.55">Lucas et al 2007</a>] and gastritis [<a class="bk_pop" href="#ipex.REF.gambineri.2008.1105">Gambineri et al 2008</a>, <a class="bk_pop" href="#ipex.REF.scaillon.2009.368">Scaillon et al 2009</a>]. Food allergies are common [<a class="bk_pop" href="#ipex.REF.torgerson.2007.1705">Torgerson et al 2007</a>].</p><p><b>Endocrinopathy</b> is present in the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Type 1 diabetes mellitus, often with onset in the first months of life, is the most common endocrine manifestation [<a class="bk_pop" href="#ipex.REF.gambineri.2008.1105">Gambineri et al 2008</a>, <a class="bk_pop" href="#ipex.REF.rubiocabezas.2009.111">Rubio-Cabezas et al 2009</a>]. Thyroid disease (thyroiditis with either hypothyroidism [more common] or hyperthyroidism) is also frequently present [<a class="bk_pop" href="#ipex.REF.wildin.2002.537">Wildin et al 2002</a>, <a class="bk_pop" href="#ipex.REF.gambineri.2003.430">Gambineri et al 2003</a>, <a class="bk_pop" href="#ipex.REF.gambineri.2008.1105">Gambineri et al 2008</a>, <a class="bk_pop" href="#ipex.REF.rubiocabezas.2009.111">Rubio-Cabezas et al 2009</a>].</p><p><b>Dermatitis.</b> The dermatitis is most frequently eczematous, but psoriasiform and ichthyosiform dermatitis have been reported as well. Other dermatologic manifestations include painful chelitis and skin lesions related to food allergies. Rare cutaneous symptoms include pemphigoid nodularis and epidermolysis bullosa acquisita [<a class="bk_pop" href="#ipex.REF.nieves.2004.466">Nieves et al 2004</a>, <a class="bk_pop" href="#ipex.REF.mcginness.2006.143">McGinness et al 2006</a>, <a class="bk_pop" href="#ipex.REF.halabitawil.2009.645">Halabi-Tawil et al 2009</a>, <a class="bk_pop" href="#ipex.REF.bis.2015.e74">Bis et al 2015</a>].</p><p><b>Autoimmune disorder.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have other autoimmune phenomena including cytopenias (autoimmune hemolytic anemia, immune thrombocytopenia, autoimmune neutropenia [<a class="bk_pop" href="#ipex.REF.barzaghi.2018.1036">Barzaghi et al 2018</a>]), autoimmune hepatitis [<a class="bk_pop" href="#ipex.REF.l_pez.2011.690">L&#x000f3;pez et al 2011</a>], and nephropathy (membranous nephropathy, interstitial nephritis, and rarely minimal change nephrotic syndrome) [<a class="bk_pop" href="#ipex.REF.park.2015.e59">Park et al 2015</a>, <a class="bk_pop" href="#ipex.REF.sheikine.2015.1197">Sheikine et al 2015</a>]. Lymphadenopathy and splenomegaly as a result of lymphoproliferation have been reported [<a class="bk_pop" href="#ipex.REF.ochs.2007.27">Ochs &#x00026;Torgerson 2007</a>, <a class="bk_pop" href="#ipex.REF.nademi.2014.310">Nademi et al 2014</a>, <a class="bk_pop" href="#ipex.REF.bacchetta.2018.5">Bacchetta et al 2018</a>, <a class="bk_pop" href="#ipex.REF.barzaghi.2018.1036">Barzaghi et al 2018</a>]. Alopecia and arthritis have also been observed [<a class="bk_pop" href="#ipex.REF.barzaghi.2018.1036">Barzaghi et al 2018</a>], as well as lung disease related to immune dysregulation [<a class="bk_pop" href="#ipex.REF.baris.2014.601">Baris et al 2014</a>].</p><p><b>Infectious complications.</b> Infections of the gastrointestinal tract, skin, and airways occur in individuals with IPEX syndrome [<a class="bk_pop" href="#ipex.REF.bacchetta.2018.5">Bacchetta et al 2018</a>], and severe or invasive infections including sepsis, meningitis, pneumonia, and osteomyelitis affect a significant number of subjects [<a class="bk_pop" href="#ipex.REF.gambineri.2008.1105">Gambineri et al 2008</a>, <a class="bk_pop" href="#ipex.REF.barzaghi.2012.211">Barzaghi et al 2012</a>, <a class="bk_pop" href="#ipex.REF.barzaghi.2018.1036">Barzaghi et al 2018</a>]. Common pathogens identified were <i>Staphylococcus</i>, <i>Enterococcus,</i> cytomegalovirus, and <i>Candida</i> [<a class="bk_pop" href="#ipex.REF.halabitawil.2009.645">Halabi-Tawil et al 2009</a>, <a class="bk_pop" href="#ipex.REF.barzaghi.2012.211">Barzaghi et al 2012</a>]. Some infections may be secondary to immunosuppressive therapy; however, many occur prior to the initiation of treatment. Serious infections in individuals with IPEX syndrome are not thought to be due to an intrinsic immune defect but instead are typically related to poor barrier function of the gut and skin [<a class="bk_pop" href="#ipex.REF.bacchetta.2018.5">Bacchetta et al 2018</a>].</p><p><b>Survival.</b> The outcome of classic IPEX syndrome is universally poor. Many children die within the first or second year of life from metabolic derangements, severe malabsorption, or sepsis. Although improvements in immunosuppressive regimens have prolonged survival, long-term immunosuppression did not appear to prevent morbidity due to disease progression and side effects or complications in the majority of patients [<a class="bk_pop" href="#ipex.REF.barzaghi.2018.1036">Barzaghi et al 2018</a>].</p><p>Early bone marrow transplantation (BMT) is able to cure IPEX; some survivors are now more than ten years post transplant and doing well. If individuals develop diabetes or thyroiditis prior to BMT, these aspects of the disorder usually persist but the other signs of IPEX resolve. Survival and long-term outcomes are improved if BMT occurs at an earlier age, prior to the individual developing irreversible organ damage related to the extensive, systemic autoimmunity present in virtually all individuals with IPEX [<a class="bk_pop" href="#ipex.REF.rao.2007.383">Rao et al 2007</a>, <a class="bk_pop" href="#ipex.REF.burroughs.2010.1000">Burroughs et al 2010</a>, <a class="bk_pop" href="#ipex.REF.kucuk.2016.953">Kucuk et al 2016</a>].</p></div><div id="ipex.Females"><h4>Females</h4><p>Heterozygous females are generally healthy. However, exceptions have been noted:</p><ul><li class="half_rhythm"><div>One <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female had an expression level of <i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> intermediate between the very low level observed in her <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> son and the normal level in a control [<a class="bk_pop" href="#ipex.REF.bennett.2001.435">Bennett et al 2001</a>].</div></li><li class="half_rhythm"><div>One <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female has monogenic diabetes mellitus [<a class="bk_pop" href="#ipex.REF.alkortaaranburu.2014.315">Alkorta-Aranburu et al 2014</a>].</div></li><li class="half_rhythm"><div><a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> studies performed on one <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female demonstrated that normal and <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <i>FOXP3</i> alleles are equally expressed in peripheral blood mononuclear cells [<a class="bk_pop" href="#ipex.REF.tommasini.2002.127">Tommasini et al 2002</a>]. However, subsequent studies of the FOXP3+ regulatory T cell population (CD4+/CD25+) demonstrated a selective advantage for cells utilizing the normal X chromosome, resulting in complete skewing of X chromosome usage in this cell subset [<a class="bk_pop" href="#ipex.REF.di_nunzio.2009.4138">Di Nunzio et al 2009</a>].</div></li><li class="half_rhythm"><div>Recurrent miscarriage of male fetuses has been reported [<a class="bk_pop" href="#ipex.REF.rae.2015.284">Rae et al 2015</a>, <a class="bk_pop" href="#ipex.REF.vasiljevic.2015.2120">Vasiljevic et al 2015</a>, <a class="bk_pop" href="#ipex.REF.xavierdasilva.2015.131">Xavier-da-Silva et al 2015</a>, <a class="bk_pop" href="#ipex.REF.reichert.2016.226">Reichert et al 2016</a>, <a class="bk_pop" href="#ipex.REF.louie.2017.1219">Louie et al 2017</a>, <a class="bk_pop" href="#ipex.REF.shehab.2017.1040">Shehab et al 2017</a>].</div></li></ul></div></div><div id="ipex.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>There is currently no <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation. The same genotype can present with variable severity in different individuals, even within the same family [<a class="bk_pop" href="#ipex.REF.seidel.2016.6">Seidel et al 2016</a>].</p><p>Furthermore, it is difficult to correlate the type of <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and outcome. Loss-of-function variants (frameshift) predicted to be missing the forkhead <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> have been described in fetal-onset and nonviable cases, but also in individuals who survive into adolescence [<a class="bk_pop" href="#ipex.REF.kobayashi.2001.874">Kobayashi et al 2001</a>, <a class="bk_pop" href="#ipex.REF.louie.2017.1219">Louie et al 2017</a>]. In addition, within the cohort of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with extremely early onset of symptoms (&#x0003c;24 h of life), the types of variants and their position within the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary [<a class="bk_pop" href="#ipex.REF.reichert.2016.226">Reichert et al 2016</a>].</p></div><div id="ipex.Nomenclature"><h3>Nomenclature</h3><p>IPEX syndrome may also be referred to as <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> autoimmunity-allergic dysregulation (XLAAD) syndrome or X-linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea (XPID).</p></div><div id="ipex.Prevalence"><h3>Prevalence</h3><p>IPEX syndrome is rare: fewer than 300 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been identified worldwide. No accurate estimates of prevalence have been published.</p></div></div><div id="ipex.Genetically_Related_Allelic_Disorde"><h2 id="_ipex_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are known to be associated with pathogenic variants in <i>FOXP3</i>.</p></div><div id="ipex.Differential_Diagnosis"><h2 id="_ipex_Differential_Diagnosis_">Differential Diagnosis</h2><p>IPEX is classified by the International Union of Immunological Societies as a disease of immune dysregulation [<a class="bk_pop" href="#ipex.REF.bousfiha.2018.129">Bousfiha et al 2018</a>]. With autoimmunity as the primary clinical manifestation, it shares features of other primary immune deficiencies associated with T regulatory cell dysfunction such as CD25 deficiency, CTL4 deficiency, and BACH2 deficiency. See <a class="figpopup" href="/books/NBK1118/table/ipex.T.syndromes_to_consider_in_the_diff/?report=objectonly" target="object" rid-figpopup="figipexTsyndromestoconsiderinthediff" rid-ob="figobipexTsyndromestoconsiderinthediff">Table 2</a> for these and other considerations in the differential diagnosis.</p><div id="ipex.T.syndromes_to_consider_in_the_diff" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Syndromes to Consider in the Differential Diagnosis of IPEX Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1118/table/ipex.T.syndromes_to_consider_in_the_diff/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ipex.T.syndromes_to_consider_in_the_diff_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Disorder</th><th id="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s) / Genetic<br />Mechanism</th><th id="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Additional Shared Clinical Features / <i>Comments</i></th></tr></thead><tbody><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other syndromes w/neonatal diabetes mellitus</b></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dmtn/">6q24-related transient neonatal diabetes mellitus</a></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2 hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Pancreatic agenesis<br />(OMIM <a href="https://omim.org/phenotypicSeries/PS260370" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS260370</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PDX1</i><br /><i>PTF1A</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Heart defects, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>, &#x00026; other <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies<br />(OMIM <a href="http://www.omim.org/entry/600001" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600001</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GATA6</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Pancreatic beta cell agenesis w/neonatal diabetes mellitus<br />(OMIM <a href="https://omim.org/entry/600089" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600089</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2 hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dmn/">Permanent neonatal diabetes mellitus</a></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCC8</i><br /><i>GCK</i><br /><i>INS</i><br /><i>KCNJ11</i><br /><i>PDX1</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />AD</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other syndromes w/polyendocrin-opathy</b></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Autoimmune polyendocrine syndrome, type I, w/ or w/out reversible metaphyseal dysplasia<br />(OMIM <a href="https://www.omim.org/entry/240300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">240300</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AIRE</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Autoimmune polyendocrine syndrome, type II<br />(OMIM <a href="http://www.omim.org/entry/269200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">269200</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="7" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other syndromes w/immunodeficiency w/&#x02193; Treg markers&#x000a0;<sup>3</sup></b></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CD25 deficiency<br />(OMIM <a href="http://www.omim.org/entry/606367" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606367</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IL2RA</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IPEX syndrome-like clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>&#x000a0;<sup>4</sup><br /><i>Distinguished from IPEX syndrome by normal IgE in CD25 deficiency</i></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">STAT5B autoimmunity &#x00026; immune deficiency syndrome<br />(OMIM <a href="http://www.omim.org/entry/245590" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">245590</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>STAT5B</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low but not absent T and NK cell numbers<br /><i>Distinguished by dwarfism in STAT5B deficiency</i>&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Immunodeficiency, common variable, 8, w/autoimmunity<br />(OMIM <a href="https://omim.org/entry/614700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614700</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LRBA</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Autoimmune enteropathy</div></li><li class="half_rhythm"><div>Type 1 diabetes mellitus</div></li><li class="half_rhythm"><div>Autoimmune hypothyroidism</div></li><li class="half_rhythm"><div>Autoimmune hemolytic anemia</div></li></ul>
</td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Autoimmune lymphoproliferative syndrome, type V<br />(OMIM <a href="https://omim.org/entry/616100" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616100</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CTLA4</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Enteropathy</div></li><li class="half_rhythm"><div>Autoimmune cytopenias</div></li><li class="half_rhythm"><div>Autoimmune thyroiditis</div></li></ul>
</td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Autoimmune disease, multisystem, infantile-onset 1 (ADMIO)<br />(OMIM <a href="https://omim.org/entry/615952" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615952</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>STAT3</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Enteropathy</div></li><li class="half_rhythm"><div>Type 1 diabetes mellitus</div></li><li class="half_rhythm"><div>Autoimmune cytopenias</div></li></ul>
<i>Distinguished by short stature in ADMIO</i>&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">BACH2-related immunodeficiency and autoimmunity&#x000a0;<sup>7</sup></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BACH2</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Enteropathy</div></li><li class="half_rhythm"><div>Chronic variable immunodeficiency</div></li></ul>
</td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Mucosa-associated lymphoid tissue lymphoma <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> 1-related syndrome&#x000a0;<sup>8</sup></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MALT1</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Enteropathy</div></li><li class="half_rhythm"><div>Dermatitis</div></li></ul>
</td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="8" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other syndromes w/immunodeficiency typically w/out &#x02193; Treg markers</b></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/was/">Wiskott-Aldrich syndrome</a></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WAS</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Thrombocytopenia</div></li><li class="half_rhythm"><div>Eczema</div></li><li class="half_rhythm"><div>Combined immune deficiency</div></li></ul>
</td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Omenn syndrome&#x000a0;<sup>9</sup><br />(OMIM <a href="http://www.omim.org/entry/603554" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">603554</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DCLRE1C</i><br /><i>RAG1</i><br /><i>RAG2</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Eosinophilia</td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Immunodeficiency 31C<br />(OMIM <a href="https://omim.org/entry/614162" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614162</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>STAT1</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Enteropathy</div></li><li class="half_rhythm"><div>Diabetes mellitus</div></li><li class="half_rhythm"><div>Dermatitis</div></li><li class="half_rhythm"><div>Autoimmune cytopenias</div></li><li class="half_rhythm"><div>Onset in infancy or early childhood</div></li></ul>
</td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hyper-IgE recurrent infection syndrome (OMIM <a href="https://omim.org/entry/243700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">243700</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DOCK8</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Atopic dermatitis</td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gastrointestinal defects &#x00026; immunodeficiency syndrome<br />(OMIM <a href="https://omim.org/entry/243150" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">243150</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTC7A</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Enteropathy<br /><i>Distinguished by intestinal atresias (variably present) in TTC7A deficiency</i>&#x000a0;<sup>10</sup></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Autoimmune polyendocrinopathy w/candidiasis &#x00026; ectodermal dystrophy (APECED)<br />(OMIM <a href="https://omim.org/entry/240300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">240300</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AIRE</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Endocrinopathy</div></li><li class="half_rhythm"><div>Enteropathy</div></li></ul>
<i>Distinguished by chronic mucocutaneous candidiasis &#x00026; ectodermal dysplasia (dental enamel hypoplasia, keratopathy) in APECED</i></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Autoimmune disease, multisystem, w/facial dysmorphism (ADMFD)<br />(OMIM <a href="https://omim.org/entry/613385" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613385</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ITCH</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Type I diabetes</div></li><li class="half_rhythm"><div>Thyroiditis</div></li><li class="half_rhythm"><div>Enteropathy</div></li></ul>
<i>Distinguished by facial dysmorphisms in ADMFD</i></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alps/">Autoimmune lymphoproliferative syndrome</a></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CASP10</i><br /><i>FAS</i><br /><i>FASLG</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR&#x000a0;<sup>11</sup></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hemolytic anemia</div></li><li class="half_rhythm"><div>Thrombocytopenia</div></li><li class="half_rhythm"><div>Splenomegaly</div></li><li class="half_rhythm"><div>Chronic adenopathy</div></li><li class="half_rhythm"><div>Type 1 diabetes mellitus</div></li><li class="half_rhythm"><div>Thyroid disease</div></li></ul>
</td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other syndromes w/protracted diarrhea in infancy&#x000a0;<sup>12</sup></b></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Microvillus inclusion disease<br />(OMIM <a href="https://omim.org/entry/251850" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">251850</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYO5B</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Tufting enteropathy<br />(OMIM <a href="https://omim.org/entry/613217" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613217</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EPCAM</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">IL-10 receptor deficiency<br />(OMIM <a href="http://www.omim.org/entry/613148" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613148</a>, <a href="https://omim.org/entry/612567" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612567</a>)</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IL10RA</i><br /><i>IL10RB</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>Distinguished by severe, early-onset, fistulating enterocolitis in IL-10 receptor deficienc</i>y&#x000a0;<sup>13</sup></td></tr><tr><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sd-thes/">Trichohepatoenteric syndrome</a></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTC37</i><br /><i>SKIV2L</i></td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ipex.T.syndromes_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; Treg = regulatory T cell; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>; &#x02193; = reduced</p></div></dd><dt>1. </dt><dd><div id="ipex.TF.2.1"><p class="no_margin">6q24-related transient neonatal diabetes mellitus is caused by overexpression of the <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> genes at 6q24 (<i>PLAGL1</i> and <i>HYMAI</i>).</p></div></dd><dt>2. </dt><dd><div id="ipex.TF.2.2"><p class="no_margin">Presumed recessive disorder or <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> defect causing an islet cell developmental defect</p></div></dd><dt>3. </dt><dd><div id="ipex.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.bousfiha.2018.129">Bousfiha et al [2018]</a></p></div></dd><dt>4. </dt><dd><div id="ipex.TF.2.4"><p class="no_margin">CD25 deficiency was identified in three individuals with an IPEX syndrome-like clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#ipex.REF.roifman.2000.6">Roifman 2000</a>, <a class="bk_pop" href="#ipex.REF.caudy.2007.482">Caudy et al 2007</a>]. In addition to autoimmunity, however, these individuals had features of severe cellular immunodeficiency with susceptibility to severe cytomegalovirus infections.</p></div></dd><dt>5. </dt><dd><div id="ipex.TF.2.5"><p class="no_margin">Individuals with STAT5B deficiency also have a form of dwarfism related to the fact that growth hormone mediates its effects through STAT5 [<a class="bk_pop" href="#ipex.REF.kofoed.2003.1139">Kofoed et al 2003</a>].</p></div></dd><dt>6. </dt><dd><div id="ipex.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.flanagan.2014.812">Flanagan et al [2014]</a></p></div></dd><dt>7. </dt><dd><div id="ipex.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.afzali.2017.813">Afzali et al [2017]</a></p></div></dd><dt>8. </dt><dd><div id="ipex.TF.2.8"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.charbithenrion.2017.378">Charbit-Henrion et al [2017]</a></p></div></dd><dt>9. </dt><dd><div id="ipex.TF.2.9"><p class="no_margin">Omenn syndrome is also known as <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> reticuloendotheliosis with eosinophilia or severe combined immunodeficiency (SCID) with hypereosinophilia.</p></div></dd><dt>10. </dt><dd><div id="ipex.TF.2.10"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.avitzur.2014.1028">Avitzur et al [2014]</a></p></div></dd><dt>11. </dt><dd><div id="ipex.TF.2.11"><p class="no_margin">Inheritance of autoimmune lymphoproliferative syndrome (ALPS)-CASP10, of most cases of ALPS-FAS, and of some cases of ALPS-FASLG is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>. Inheritance of most cases of ALPS-FASLG and of severe ALPS associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> FAS pathogenic variants is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p></div></dd><dt>12. </dt><dd><div id="ipex.TF.2.12"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.sherman.2004.16">Sherman et al [2004]</a></p></div></dd><dt>13. </dt><dd><div id="ipex.TF.2.13"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.glocker.2009.2033">Glocker et al [2009]</a></p></div></dd></dl></div></div></div></div><div id="ipex.Management"><h2 id="_ipex_Management_">Management</h2><div id="ipex.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with IPEX syndrome, the evaluations summarized in <a class="figpopup" href="/books/NBK1118/table/ipex.T.recommended_evaluations_following/?report=objectonly" target="object" rid-figpopup="figipexTrecommendedevaluationsfollowing" rid-ob="figobipexTrecommendedevaluationsfollowing">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><div id="ipex.T.recommended_evaluations_following" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with IPEX Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1118/table/ipex.T.recommended_evaluations_following/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ipex.T.recommended_evaluations_following_lrgtbl__"><table><tbody><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Organ System</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Evaluation</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Comment</b></td></tr><tr><td rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nutrition assessment</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To include serum electrolyte levels, calcium, magnesium, zinc, serum albumin &#x00026; pre-albumin</td></tr><tr><td colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hepatic assessment</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To include serum AST, ALT, GGT, &#x00026; total bilirubin &#x00026; assessment of hepatic autoantibodies</td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrine</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Glucose tolerance test</div></li><li class="half_rhythm"><div>HgA1C</div></li><li class="half_rhythm"><div>Thyroid function tests</div></li><li class="half_rhythm"><div>Autoantibodies to pancreatic islet antigens &#x00026; thyroid antigens</div></li></ul>
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Immunologic</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Serum IgG, IgM, IgA, &#x00026; IgE concentrations</div></li><li class="half_rhythm"><div>Regulatory T cell numbers</div></li></ul>
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dermatologic</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation of any skin lesions</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May include histology</td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hematologic</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Complete blood count &#x00026; differential</div></li><li class="half_rhythm"><div>Coombs test</div></li><li class="half_rhythm"><div>Evaluation of autoimmune hypercoagulability (anti-phospholipid antibodies, lupus anticoagulant)</div></li></ul>
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>BUN, creatinine</div></li><li class="half_rhythm"><div>Urinalysis</div></li></ul>
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/Other</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="ipex.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Bone marrow transplantation (BMT) offers the only potential cure for IPEX syndrome. Early attempts at BMT using myeloablative conditioning regimens met with only limited success because of transplant-related mortality and other complications related to the underlying disease [<a class="bk_pop" href="#ipex.REF.baud.2001.1758">Baud et al 2001</a>]. Approaches using non-myeloablative conditioning regimens have markedly improved outcomes and survival [<a class="bk_pop" href="#ipex.REF.burroughs.2007.633">Burroughs et al 2007</a>, <a class="bk_pop" href="#ipex.REF.lucas.2007.55">Lucas et al 2007</a>, <a class="bk_pop" href="#ipex.REF.rao.2007.383">Rao et al 2007</a>]. While generally less toxic, these reduced-intensity conditioning regimens still appear to generate long-term, stable engraftment of a donor regulatory T cell population [<a class="bk_pop" href="#ipex.REF.burroughs.2010.1000">Burroughs et al 2010</a>, <a class="bk_pop" href="#ipex.REF.nademi.2014.310">Nademi et al 2014</a>, <a class="bk_pop" href="#ipex.REF.barzaghi.2018.1036">Barzaghi et al 2018</a>] and, if performed in early infancy, may prevent the development of irreversible diabetes mellitus or thyroiditis [<a class="bk_pop" href="#ipex.REF.burroughs.2010.1000">Burroughs et al 2010</a>].</p><p>A large, multicenter long-term follow-up study suggests that bone marrow transplantation at time of no or mild organ impairment results in improved resolution of autoimmunity, especially when compared with non-transplanted individuals under chronic immunosuppressive therapy [<a class="bk_pop" href="#ipex.REF.barzaghi.2012.211">Barzaghi et al 2012</a>].</p><div id="ipex.T.treatment_of_manifestations_in_in" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with IPEX Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1118/table/ipex.T.treatment_of_manifestations_in_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ipex.T.treatment_of_manifestations_in_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation</th><th id="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Enteropathy of IPEX syndrome</b></td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor fluid intake to assure adequate intravascular volume.</td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Nutritional support including TPN or elemental or low-carbohydrate-containing formula is necessary in almost all individuals.</td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">T cell-directed immune suppression (i.e., sirolimus, cyclosporin A or tacrolimus), either alone or in combination with steroids</td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Toxicity, tachyphylaxis, &#x00026; increased susceptibility to infection related to chronic use of these agents reduce their potential for long-term amelioration of symptoms in most individuals.</td></tr><tr><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sirolimus (rapamycin) as monotherapy or in combination w/other drugs&#x000a0;<sup>4</sup> is considered first-line treatment; calcineurin inhibitors (e.g. tacrolimus) as an alternative&#x000a0;<sup>5</sup>.</td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Used successfully in individuals for whom tacrolimus was either ineffective or toxic&#x000a0;<sup>1</sup></div></li><li class="half_rhythm"><div>The ability of sirolimus to suppress effector T cell function while allowing Treg cells to continue to develop &#x00026; function offers some theoretic advantages for its use.&#x000a0;<sup>2</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrinopathy</b></td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment protocols for diabetes mellitus &#x00026; autoimmune thyroid disease</td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dermatitis</b></td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Systemic T cell-directed immune suppression</div></li><li class="half_rhythm"><div>Topical therapies (e.g., steroids, tacrolimus, emollients) can also be beneficial.</div></li></ul>
</td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For severe dermatitis, wound care specialist can be very helpful</td></tr><tr><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Immune dysregulation</b></td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>For autoimmune neutropenia: granulocyte colony stimulating factor (G-CSF) can improve neutrophil counts.</div></li><li class="half_rhythm"><div>For pemphigus nodularis &#x00026; other autoantibody-mediated disease: Rituximab has been effective&#x000a0;<sup>3</sup>.</div></li></ul>
</td><td headers="hd_h_ipex.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be beneficial</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ipex.TF.4.1"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.bindl.2005.256">Bindl et al [2005]</a>, <a class="bk_pop" href="#ipex.REF.yong.2008.581">Yong et al [2008]</a></p></div></dd><dt>2. </dt><dd><div id="ipex.TF.4.2"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.strauss.2007.320">Strauss et al [2007]</a></p></div></dd><dt>3. </dt><dd><div id="ipex.TF.4.3"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.mcginness.2006.143">McGinness et al [2006]</a></p></div></dd><dt>4. </dt><dd><div id="ipex.TF.4.4"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.bacchetta.2018.5">Bacchetta et al [2018]</a></p></div></dd><dt>5. </dt><dd><div id="ipex.TF.4.5"><p class="no_margin"><a class="bk_pop" href="#ipex.REF.barzaghi.2018.1036">Barzaghi et al [2018]</a></p></div></dd></dl></div></div></div></div><div id="ipex.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Individuals with autoimmune neutropenia or recurrent infections resulting from severe eczema may benefit from prophylactic antibiotic therapy to decrease the risk of severe infectious complications.</p><p>Aggressive management of dermatitis with topical steroids and anti-inflammatory agents can help to prevent infections from pathogens that enter as a result of the poor barrier function of the skin.</p></div><div id="ipex.Surveillance"><h3>Surveillance</h3><p>Monitoring for evidence of autoimmune disease is recommended every three to six months with the following tests: complete blood count, thyroid function, HbA1c and glucose, kidney function (measurement of serum concentration of BUN, creatinine), and liver function (measurement of serum concentration of AST, ALT). Frequent monitoring of growth parameters, nutritional intake, and stooling patterns is important. If under immunosuppression of post-transplantation, monitoring for drug side effects should adhere to standard guidelines.</p></div><div id="ipex.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Immune activation (e.g., by immunizations or severe infections) has been reported to cause worsening or exacerbation of disease symptoms [<a class="bk_pop" href="#ipex.REF.powell.1982.731">Powell et al 1982</a>]. It is generally best practice to withhold immunizations until after bone marrow transplantation, if possible.</p></div><div id="ipex.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of at-risk males either prenatally or immediately after birth to enable early diagnosis and BMT and/or steroid treatment in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males before significant organ damage occurs.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known;</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not known, monitoring of at-risk males for early-onset diarrhea, diabetes mellitus, thyroid dysfunction, and autoimmune hematologic manifestations.</div></li></ul><p>See <a href="#ipex.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ipex.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="ipex.Genetic_Counseling"><h2 id="_ipex_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ipex.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>IPEX syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="ipex.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). Note: If a woman has more than one affected child and no other affected relatives and if the <i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Maternal somatic and germline mosaicism has been reported in IPEX syndrome [<a class="bk_pop" href="#ipex.REF.lin.2018.885">Lin et al 2018</a>].</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a carrier. The percentage of affected males who have no family history of IPEX is not known.</div></li><li class="half_rhythm"><div>Female carriers of IPEX syndrome are typically asymptomatic (see Clinical Description, <a href="#ipex.Females">Females</a>).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the variant will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (carriers) and will typically be unaffected.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the proband's mother, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is slightly greater than that of the general population (though still &#x0003c;1%) due to the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#ipex.REF.lin.2018.885">Lin et al 2018</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b>. Affected males transmit the <i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to:</p><ul><li class="half_rhythm"><div>All of their daughters, who will be (heterozygotes) carriers and will typically not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (see Clinical Description, <a href="#ipex.Females">Females</a>);</div></li><li class="half_rhythm"><div>None of their sons.</div></li></ul><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts and their offspring may be at risk of being heterozygotes (carriers) for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the aunts' offspring, depending on their gender, may be at risk of being heterozygotes for the pathogenic variant or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="ipex.Heterozygote_Carrier_Detection"><h3>Heterozygote (Carrier) Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p><a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> is skewed only in regulatory T cells [<a class="bk_pop" href="#ipex.REF.di_nunzio.2009.4138">Di Nunzio et al 2009</a>] and is random in all other lymphocyte populations [<a class="bk_pop" href="#ipex.REF.tommasini.2002.127">Tommasini et al 2002</a>]; therefore, X-chromosome inactivation studies are of limited use in <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> detection.</p></div><div id="ipex.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#ipex.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ipex.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>FOXP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="ipex.Resources"><h2 id="_ipex_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Diabetes Association (ADA)</b></div><div><b>Phone:</b> 1-800-DIABETES (800-342-2383)</div><div><b>Email:</b> AskADA@diabetes.org</div><div><a href="http://www.diabetes.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.diabetes.org</a></div></li><li class="half_rhythm"><div><b>Diabetes UK</b></div><div>United Kingdom</div><div><b>Phone:</b> 0345 123 2399</div><div><b>Fax:</b> 020 7424 1001</div><div><b>Email:</b> info@diabetes.org.uk</div><div><a href="http://www.diabetes.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.diabetes.org.uk</a></div></li><li class="half_rhythm"><div><b>International Patient Organisation for Primary Immunodeficiencies (IPOPI)</b></div><div>Firside</div><div>Main Road</div><div>Downderry Cornwall PL11 3LE</div><div>United Kingdom</div><div><b>Phone:</b> +44 01503 250 668</div><div><b>Fax:</b> +44 01503 250 668</div><div><b>Email:</b> info@ipopi.org</div><div><a href="http://ipopi.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ipopi.org</a></div></li><li class="half_rhythm"><div><b>Jeffrey Modell Foundation/National Primary Immunodeficiency Resource Center</b></div><div>747 Third Avenue</div><div>New York NY 10017</div><div><b>Phone:</b> 866-463-6474 (toll-free); 212-819-0200</div><div><b>Fax:</b> 212-764-4180</div><div><b>Email:</b> info@jmfworld.org</div><div><a href="http://www.info4pi.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.info4pi.org</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>Latin American Society for Immunodeficiency (LASID) Registry</b></div><div><b>Email:</b> lagid.adm@gmail.com</div><div><a href="https://registrolasid.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lasid.org</a></div></li></ul></div><div id="ipex.Molecular_Genetics"><h2 id="_ipex_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ipex.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>IPEX Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1118/table/ipex.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ipex.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ipex.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ipex.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ipex.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ipex.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ipex.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ipex.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ipex.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/50943" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FOXP3</i></a></td><td headers="hd_b_ipex.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=50943" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_ipex.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9BZS1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Forkhead box protein P3</a></td><td headers="hd_b_ipex.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/FOXP3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FOXP3 @ LOVD</a><br /><a href="https://research.cchmc.org/LOVD2/home.php?select_db=FOXP3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (FOXP3)</a></td><td headers="hd_b_ipex.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FOXP3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FOXP3</a></td><td headers="hd_b_ipex.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FOXP3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FOXP3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ipex.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ipex.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for IPEX Syndrome (<a href="/omim/300292,304790" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1118/table/ipex.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ipex.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300292" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300292</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FORKHEAD BOX P3; FOXP3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/304790" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">304790</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>FOXP3</i> contains 12 exons. The first <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> is untranslated and is followed by a large <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> that contains key regulatory elements (particularly the Treg-specific demethylated region) that are critical for controlling which cells express the FOXP3 protein [<a class="bk_pop" href="#ipex.REF.huehn.2009.83">Huehn et al 2009</a>]. The 11 translated exons of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encode the FOXP3 protein. For a detailed summary of gene and protein information, see <a href="/books/NBK1118/#ipex.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of pathogenic variants in <i>FOXP3</i> are either <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants or small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> amino acid deletions. Loss-of-function variants have been described both in individuals with a neonatal presentation and others with a childhood presentation so that <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of <i>FOXP3</i> does not appear to be lethal. The highest concentration of variants cluster within the C-terminal forkhead DNA-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. Some pathogenic variants also affect the leucine zipper and an amino-terminal proline-rich domain that is involved in interactions with other key protein partners. Clustering of variants within these key functional regions of the protein demonstrates the essential role for these domains in FOXP3 function [<a class="bk_pop" href="#ipex.REF.chatila.2000.r75">Chatila et al 2000</a>, <a class="bk_pop" href="#ipex.REF.lopes.2006.3133">Lopes et al 2006</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>FOXP3</i> encodes forkhead box protein P3 (FOXP3), a forkhead DNA-binding protein that is expressed primarily in CD4+CD25+ regulatory T cells. The protein consists of 431 amino acids and has important functional domains including:</p><ul><li class="half_rhythm"><div>An N-terminal proline-rich <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, which is essential for the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-suppressive function of FOXP3 and for interaction with other key transcription factors including ROR&#x003b1; and ROR&#x003b3;t [<a class="bk_pop" href="#ipex.REF.du.2008.4785">Du et al 2008</a>, <a class="bk_pop" href="#ipex.REF.zhou.2008.236">Zhou et al 2008</a>];</div></li><li class="half_rhythm"><div>A C2H2 zinc finger and leucine zipper (both conserved structural motifs involved in protein-protein interactions) in the central portion;</div></li><li class="half_rhythm"><div>A forkhead DNA-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> at the C terminus from which it derives its name (forkhead box) [<a class="bk_pop" href="#ipex.REF.ochs.2005.156">Ochs et al 2005</a>, <a class="bk_pop" href="#ipex.REF.lopes.2006.3133">Lopes et al 2006</a>]. A putative nuclear localization signal is located at the C-terminal portion of the forkhead domain [<a class="bk_pop" href="#ipex.REF.lopes.2006.3133">Lopes et al 2006</a>].</div></li></ul><p>Proteins bearing forkhead DNA-binding motifs comprise a large family of related DNA-binding proteins that play diverse roles in enhancing or suppressing transcription from specific binding sites. Several members of this protein family are involved in patterning and development [<a class="bk_pop" href="#ipex.REF.gajiwala.2000.110">Gajiwala &#x00026; Burley 2000</a>]. FOXP3 is expressed primarily in lymphoid tissues (thymus, spleen, and lymph nodes), particularly in CD4+ CD25+ regulatory T lymphocytes. In mice, it is required for the development and suppressive function of this important regulatory T cell population [<a class="bk_pop" href="#ipex.REF.fontenot.2003.330">Fontenot et al 2003</a>, <a class="bk_pop" href="#ipex.REF.hori.2003.1057">Hori et al 2003</a>, <a class="bk_pop" href="#ipex.REF.khattri.2003.337">Khattri et al 2003</a>, <a class="bk_pop" href="#ipex.REF.sakaguchi.2003.1310">Sakaguchi 2003</a>]. In humans, it is not expressed at baseline in CD4+CD25- or CD8+ T cells but is expressed upon T cell activation [<a class="bk_pop" href="#ipex.REF.gavin.2006.6659">Gavin et al 2006</a>, <a class="bk_pop" href="#ipex.REF.allan.2007.345">Allan et al 2007</a>]. The significance of this inducible expression in effector T cells is unknown.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss of function or <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is the molecular mechanism of IPEX syndrome. Pathogenic alterations can affect <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> stability, protein function, and intracellular localization. The FOXP3 protein is a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> that regulates the expression of hundreds of targets and is necessary for proper development of Treg, a population of cells responsible for tolerance of self-antigens.</p><p>A subset of the identified <i>FOXP3</i> pathogenic variants have decreased function and cause a milder form of the disease [<a class="bk_pop" href="#ipex.REF.de_benedetti.2006.653">De Benedetti et al 2006</a>, <a class="bk_pop" href="#ipex.REF.gambineri.2008.1105">Gambineri et al 2008</a>].</p></div><div id="ipex.References"><h2 id="_ipex_References_">References</h2><div id="ipex.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.afzali.2017.813">Afzali B, Gronholm J, Vandrovcova J, O'Brien C, Sun HW, Vanderleyden I, Davis FP, Khoder A, Zhang Y, Hegazy AN, Villarino AV, Palmer IW, Kaufman J, Watts NR, Kazemian M, Kamenyeva O, Keith J, Sayed A, Kasperaviciute D, Mueller M, Hughes JD, Fuss IJ, Sadiyah MF, Montgomery-Recht K, McElwee J, Restifo NP, Strober W, Linterman MA, Wingfield PT, Uhlig HH, Roychoudhuri R, Aitman TJ, Kelleher P, Lenardo MJ, O'Shea JJ, Cooper N, Laurence ADJ. BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency. <span><span class="ref-journal">Nat Immunol. </span>2017;<span class="ref-vol">18</span>:813–23.</span> [<a href="/pmc/articles/PMC5593426/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5593426</span></a>] [<a href="/pubmed/28530713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28530713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.alkortaaranburu.2014.315">Alkorta-Aranburu G, Carmody D, Cheng YW, Nelakuditi V, Ma L, Dickens JT, Das S, Greeley SAW, Del Gaudio D. Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. <span><span class="ref-journal">Mol Genet Metab. </span>2014;<span class="ref-vol">113</span>:315–20.</span> [<a href="/pmc/articles/PMC4756642/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4756642</span></a>] [<a href="/pubmed/25306193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25306193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.allan.2007.345">Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. <span><span class="ref-journal">Int Immunol. </span>2007;<span class="ref-vol">19</span>:345–54.</span> [<a href="/pubmed/17329235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17329235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.avitzur.2014.1028">Avitzur Y, Guo C, Mastropaolo LA, Bahrami E, Chen H, Zhao Z, Elkadri A, Dhillon S, Murchie R, Fattouh R, Huynh H, Walker JL, Wales PW, Cutz E, Kakuta Y, Dudley J, Kammermeier J, Powrie F, Shah N, Walz C, Nathrath M, Kotlarz D, Puchaka J, Krieger JR, Racek T, Kirchner T, Walters TD, Brumell JH, Griffiths AM, Rezaei N, Rashtian P, Najafi M, Monajemzadeh M, Pelsue S, McGovern DP, Uhlig HH, Schadt E, Klein C, Snapper SB, Muise AM. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. <span><span class="ref-journal">Gastroenterology. </span>2014;<span class="ref-vol">146</span>:1028–39.</span> [<a href="/pmc/articles/PMC4002656/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4002656</span></a>] [<a href="/pubmed/24417819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24417819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.bacchetta.2018.5">Bacchetta R, Barzaghi F, Roncarolo MG. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2018;<span class="ref-vol">1417</span>:5–22.</span> [<a href="/pubmed/26918796" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26918796</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.baris.2014.601">Baris S, Schulze I, Ozen A, Karakoc Aydiner E, Altuncu E, Karasu GT, Ozturk N, Lorenz M, Schwarz K, Vraetz T, Ehl S, Barlan IB. Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation. <span><span class="ref-journal">J Clin Immunol. </span>2014;<span class="ref-vol">34</span>:601–6.</span> [<a href="/pubmed/24916357" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24916357</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.barzaghi.2018.1036">Barzaghi F, Amaya Hernandez LC, Neven B, Ricci S, Kucuk ZY, Bleesing JJ, Nademi Z, Slatter MA, Ulloa ER, Shcherbina A, Roppelt A, Worth A, Silva J, Aiuti A, Murguia-Favela L, Speckmann C, Carneiro-Sampaio M, Fernandes JF, Baris S, Ozen A, Karakoc-Aydiner E, Kiykim A, Schulz A, Steinmann S, Notarangelo LD, Gambineri E, Lionetti P, Shearer WT, Forbes LR, Martinez C, Moshous D, Blanche S, Fisher A, Ruemmele FM, Tissandier C, Ouachee-Chardin M, Rieux-Laucat F, Cavazzana M, Qasim W, Lucarelli B, Albert MH, Kobayashi I, Alonso L, Diaz De Heredia C, Kanegane H, Lawitschka A, Seo JJ, Gonzalez-Vicent M, Diaz MA, Goyal RK, Sauer MG, Yesilipek A, Kim M, Yilmaz-Demirdag Y, Bhatia M, Khlevner J, Richmond Padilla EJ, Martino S, Montin D, Neth O, Molinos-Quintana A, Valverde-Fernandez J, Broides A, Pinsk V, Ballauf A, Haerynck F, Bordon V, Dhooge C, Garcia-Lloret ML, Bredius RG, Ka&#x00142;wak K, Haddad E, Seidel MG, Duckers G, Pai SY, Dvorak CC, Ehl S, Locatelli F, Goldman F, Gennery AR, Cowan MJ, Roncarolo MG, Bacchetta R., Primary Immune Deficiency Treatment Consortium (PIDTC) and the Inborn Errors Working Party (IEWP) of the European Society for Blood and Marrow Transplantation (EBMT).  Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2018;<span class="ref-vol">141</span>:1036–49.e5.</span> [<a href="/pmc/articles/PMC6050203/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6050203</span></a>] [<a href="/pubmed/29241729" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29241729</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.barzaghi.2012.211">Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. <span><span class="ref-journal">Front Immunol. </span>2012;<span class="ref-vol">3</span>:211.</span> [<a href="/pmc/articles/PMC3459184/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3459184</span></a>] [<a href="/pubmed/23060872" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23060872</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.baud.2001.1758">Baud O, Goulet O, Canioni D, Le Deist F, Radford I, Rieu D, Dupuis-Girod S, Cerf-Bensussan N, Cavazzana-Calvo M, Brousse N, Fischer A, Casanova JL. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. <span><span class="ref-journal">N Engl J Med. </span>2001;<span class="ref-vol">344</span>:1758–62.</span> [<a href="/pubmed/11396442" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11396442</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.bennett.2001.435">Bennett CL, Brunkow ME, Ramsdell F, O'Briant KC, Zhu Q, Fuleihan RL, Shigeoka AO, Ochs HD, Chance PF. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA--&#x0003e;AAUGAA) leads to the IPEX syndrome. <span><span class="ref-journal">Immunogenetics. </span>2001;<span class="ref-vol">53</span>:435–9.</span> [<a href="/pubmed/11685453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11685453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.bindl.2005.256">Bindl L, Torgerson T, Perroni L, Youssef N, Ochs HD, Goulet O, Ruemmele FM. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). <span><span class="ref-journal">J Pediatr. </span>2005;<span class="ref-vol">147</span>:256–9.</span> [<a href="/pubmed/16126062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16126062</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.bis.2015.e74">Bis S, Maguiness SM, Gellis SE, Schneider LC, Lee PY, Notarangelo LD, Keles S, Chatila TA, Schmidt BA, Miller DD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with neonatal epidermolysis bullosa acquisita. <span><span class="ref-journal">Pediatr Dermatol. </span>2015;<span class="ref-vol">32</span>:e74–7.</span> [<a href="/pubmed/25790289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25790289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.bousfiha.2018.129">Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H, Al-Herz W, Chatila T, Crow YJ, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T, Ochs HD, Oksenhendler E, Puck J, Tang MLK, Tangye SG, Torgerson TR, Casanova JL, Sullivan KE. The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies. <span><span class="ref-journal">J Clin Immunol. </span>2018;<span class="ref-vol">38</span>:129–43.</span> [<a href="/pmc/articles/PMC5742599/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5742599</span></a>] [<a href="/pubmed/29226301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29226301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.burroughs.2007.633">Burroughs LM, Storb R, Leisenring WM, Pulsipher MA, Loken MR, Torgerson TR, Ochs HD, Woolfrey AE. Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders. <span><span class="ref-journal">Bone Marrow Transplant. </span>2007;<span class="ref-vol">40</span>:633–42.</span> [<a href="/pubmed/17660844" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17660844</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.burroughs.2010.1000">Burroughs LM, Torgerson TR, Storb R, Carpenter PA, Rawlings DJ, Sanders MD, Scharenberg AM, Skoda-Smith S, Englund J, Ochs HD, Woolfrey AE. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2010;<span class="ref-vol">126</span>:1000–5.</span> [<a href="/pmc/articles/PMC2962731/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2962731</span></a>] [<a href="/pubmed/20643476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20643476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.caudy.2007.482">Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2007;<span class="ref-vol">119</span>:482–7.</span> [<a href="/pubmed/17196245" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17196245</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.charbithenrion.2017.378">Charbit-Henrion F, Jeverica AK, Begue B, Markelj G, Parlato M, Avcin SL, Callebaut I, Bras M, Parisot M, Jazbec J, Homan M, Ihan A, Rieux-Laucat F, Stolzenberg MC, Ruemmele FM, Av&#x0010d;in T, Cerf-Bensussan N. GENIUS Group. Deficiency in mucosa-associated lymphoid tissue lymphoma translocation 1: a novel cause of IPEX-like syndrome. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2017;<span class="ref-vol">64</span>:378–84.</span> [<a href="/pubmed/27253662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27253662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.chatila.2000.r75">Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM. Jm2, encoding a fork head-related protein, is mutated in x-linked autoimmunity-allergic dysregulation syndrome. <span><span class="ref-journal">J Clin Invest. </span>2000;<span class="ref-vol">106</span>:R75–81.</span> [<a href="/pmc/articles/PMC387260/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC387260</span></a>] [<a href="/pubmed/11120765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11120765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.de_benedetti.2006.653">De Benedetti F, Insalaco A, Diamanti A, Cortis E, Muratori F, Lamioni A, Carsetti R, Cusano R, De Vito R, Perroni L, Gambarara M, Castro M, Bottazzo GF, Ugazio AG. Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2006;<span class="ref-vol">4</span>:653–9.</span> [<a href="/pubmed/16630773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16630773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.di_nunzio.2009.4138">Di Nunzio S, Cecconi M, Passerini L, McMurchy AN, Baron U, Turbachova I, Vignola S, Valencic E, Tommasini A, Junker A, Cazzola G, Olek S, Levings MK, Perroni L, Roncarolo MG, Bacchetta R. Wild-type <em>FOXP3</em> is selectively active in CD4<sup>+</sup>CD25hi regulatory T cells of healthy female carriers of different <em>FOXP3</em> mutations. <span><span class="ref-journal">Blood. </span>2009;<span class="ref-vol">114</span>:4138–41.</span> [<a href="/pubmed/19738030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19738030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.dotta.2002.283">Dotta F, Vendrame F. Neonatal syndromes of polyendocrinopathy. <span><span class="ref-journal">Endocrinol Metab Clin North Am. </span>2002;<span class="ref-vol">31</span>:283–93.</span> [<a href="/pubmed/12092451" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12092451</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.du.2008.4785">Du J, Huang C, Zhou B, Ziegler SF. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. <span><span class="ref-journal">J Immunol. </span>2008;<span class="ref-vol">180</span>:4785–92.</span> [<a href="/pubmed/18354202" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18354202</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.flanagan.2014.812">Flanagan SE, Haapaniemi E, Russell MA, Caswell R, Allen HL, De Franco E, McDonald TJ, Rajala H, Ramelius A, Barton J, Heiskanen K, Heiskanen-Kosma T, Kajosaari M, Murphy NP, Milenkovic T, Sepp&#x000e4;nen M, Lernmark &#x000c5;, Mustjoki S, Otonkoski T, Kere J, Morgan NG, Ellard S, Hattersley AT. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. <span><span class="ref-journal">Nat Genet. </span>2014;<span class="ref-vol">46</span>:812–4.</span> [<a href="/pmc/articles/PMC4129488/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4129488</span></a>] [<a href="/pubmed/25038750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25038750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.fontenot.2003.330">Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. <span><span class="ref-journal">Nat Immunol. </span>2003;<span class="ref-vol">4</span>:330–6.</span> [<a href="/pubmed/12612578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12612578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.gajiwala.2000.110">Gajiwala KS, Burley SK. Winged helix proteins. <span><span class="ref-journal">Curr Opin Struct Biol. </span>2000;<span class="ref-vol">10</span>:110–6.</span> [<a href="/pubmed/10679470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10679470</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.gambineri.2008.1105">Gambineri E, Perroni L, Passerini L, Bianchi L, Doglioni C, Meschi F, Bonfanti R, Sznajer Y, Tommasini A, Lawitschka A, Junker A, Dunstheimer D, Heidemann PH, Cazzola G, Cipolli M, Friedrich W, Janic D, Azzi N, Richmond E, Vignola S, Barabino A, Chiumello G, Azzari C, Roncarolo MG, Bacchetta R. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: Inconsistent correlation between forkhead box protein 3 expression and disease severity. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2008;<span class="ref-vol">122</span>:1105–12.e1.</span> [<a href="/pubmed/18951619" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18951619</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.gambineri.2003.430">Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. <span><span class="ref-journal">Curr Opin Rheumatol. </span>2003;<span class="ref-vol">15</span>:430–5.</span> [<a href="/pubmed/12819471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12819471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.gavin.2006.6659">Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, Ocheltree EL, Greenberg PD, Ochs HD, Rudensky AY. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:6659–64.</span> [<a href="/pmc/articles/PMC1458937/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1458937</span></a>] [<a href="/pubmed/16617117" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16617117</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.ge.2017.267">Ge T, Wang YZ, Che YR, Xiao YM, Zhang T. Atypical late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome with intractable diarrhea: a case report. <span><span class="ref-journal">Front Pediatr. </span>2017;<span class="ref-vol">5</span>:267.</span> [<a href="/pmc/articles/PMC5732958/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5732958</span></a>] [<a href="/pubmed/29312905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29312905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.glocker.2009.2033">Glocker EO, Kotlarz D, Boztug K, Gertz EM, Sch&#x000e4;ffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, H&#x000e4;tscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">361</span>:2033–45.</span> [<a href="/pmc/articles/PMC2787406/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2787406</span></a>] [<a href="/pubmed/19890111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19890111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.halabitawil.2009.645">Halabi-Tawil M, Ruemmele FM, Fraitag S, Rieux-Laucat F, Neven B, Brousse N, De Prost Y, Fischer A, Goulet O, Bodemer C. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. <span><span class="ref-journal">Br J Dermatol. </span>2009;<span class="ref-vol">160</span>:645–51.</span> [<a href="/pubmed/18795917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18795917</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.hori.2003.1057">Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">299</span>:1057–61.</span> [<a href="/pubmed/12522256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12522256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.huehn.2009.83">Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? <span><span class="ref-journal">Nat Rev Immunol. </span>2009;<span class="ref-vol">9</span>:83–9.</span> [<a href="/pubmed/19114986" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19114986</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.hwang.2018.388">Hwang JL, Park SY, Ye H, Sanyoura M, Pastore AN, Carmody D, Del Gaudio D, Wilson JF, Hanis CL, Liu X, Atzmon G, Glaser B, Philipson LH, Greeley SAW. T2D-Genes Consortium. FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. <span><span class="ref-journal">Pediatr Diabetes. </span>2018;<span class="ref-vol">19</span>:388–92.</span> [<a href="/pmc/articles/PMC5918222/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5918222</span></a>] [<a href="/pubmed/29193502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29193502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.khattri.2003.337">Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. <span><span class="ref-journal">Nat Immunol. </span>2003;<span class="ref-vol">4</span>:337–42.</span> [<a href="/pubmed/12612581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12612581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.kobayashi.2001.874">Kobayashi I, Shiari R, Yamada M, Kawamura N, Okano M, Yara A, Iguchi A, Ishikawa N, Ariga T, Sakiyama Y, Ochs HD, Kobayashi K. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). <span><span class="ref-journal">J Med Genet. </span>2001;<span class="ref-vol">38</span>:874–6.</span> [<a href="/pmc/articles/PMC1734795/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734795</span></a>] [<a href="/pubmed/11768393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11768393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.kofoed.2003.1139">Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG. Growth hormone insensitivity associated with a STAT5b mutation. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">349</span>:1139–47.</span> [<a href="/pubmed/13679528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13679528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.kucuk.2016.953">Kucuk ZY, Bleesing JJ, Marsh R, Zhang K, Davies S, Filipovich AH. A challenging undertaking: Stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2016;<span class="ref-vol">137</span>:953–5.e4.</span> [<a href="/pubmed/26559324" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26559324</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.lin.2018.885">Lin Y, Xu A, Zeng C, Cheng J, Li N, Niu H, Liu L, Li X. Somatic and germline FOXP3 mosaicism in the mother of a boy with IPEX syndrome. <span><span class="ref-journal">Eur J Immunol. </span>2018;<span class="ref-vol">48</span>:885–7.</span> [<a href="/pubmed/29400909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29400909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.lopes.2006.3133">Lopes JE, Torgerson TR, Schubert LA, Anover SD, Ocheltree EL, Ochs HD, Ziegler SF. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">177</span>:3133–42.</span> [<a href="/pubmed/16920951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16920951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.l_pez.2011.690">L&#x000f3;pez SI, Ciocca M, Oleastro M, Cuarterolo ML, Rocca A, de D&#x000e1;vila MT, Roy A, Fern&#x000e1;ndez MC, Nievas E, Bosaleh A, Torgerson TR, Ruiz JA. Autoimmune hepatitis type 2 in a child with IPEX syndrome. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2011;<span class="ref-vol">53</span>:690–3.</span> [<a href="/pubmed/21629128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21629128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.louie.2017.1219">Louie RJ, Tan QK, Gilner JB, Rogers RC, Younge N, Wechsler SB, McDonald MT, Gordon B, Saski CA, Jones JR, Chapman SJ, Stevenson RE, Sleasman JW, Friez MJ. Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:1219–25.</span> [<a href="/pmc/articles/PMC5515470/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5515470</span></a>] [<a href="/pubmed/28317311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28317311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.lucas.2007.55">Lucas KG, Ungar D, Comito M, Bayerl M, Groh B. Submyeloablative cord blood transplantation corrects clinical defects seen in IPEX syndrome. <span><span class="ref-journal">Bone Marrow Transplant. </span>2007;<span class="ref-vol">39</span>:55–6.</span> [<a href="/pubmed/17115064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17115064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.mcginness.2006.143">McGinness JL, Bivens MM, Greer KE, Patterson JW, Saulsbury FT. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. <span><span class="ref-journal">J Am Acad Dermatol. </span>2006;<span class="ref-vol">55</span>:143–8.</span> [<a href="/pubmed/16781310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16781310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.nademi.2014.310">Nademi Z, Slatter M, Gambineri E, Mannurita SC, Barge D, Hodges S, Bunn S, Thomas J, Haugk B, Hambleton S, Flood T, Cant A, Abinun M, Gennery A. Single centre experience of haematopoietic SCT for patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. <span><span class="ref-journal">Bone Marrow Transplant. </span>2014;<span class="ref-vol">49</span>:310–2.</span> [<a href="/pubmed/24270390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24270390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.nieves.2004.466">Nieves DS, Phipps RP, Pollock SJ, Ochs HD, Zhu Q, Scott GA, Ryan CK, Kobayashi I, Rossi TM, Goldsmith LA. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. <span><span class="ref-journal">Arch Dermatol. </span>2004;<span class="ref-vol">140</span>:466–72.</span> [<a href="/pubmed/15096376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15096376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.ochs.2007.27">Ochs HD, Torgerson TR. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked inheritance: model for autoaggression. <span><span class="ref-journal">Adv Exp Med Biol. </span>2007;<span class="ref-vol">601</span>:27–36.</span> [<a href="/pubmed/17712989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17712989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.ochs.2005.156">Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of the immune response. <span><span class="ref-journal">Immunol Rev. </span>2005;<span class="ref-vol">203</span>:156–64.</span> [<a href="/pubmed/15661028" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15661028</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.park.2015.e59">Park E, Chang HJ, Shin JI, Lim BJ, Jeong HJ, Lee KB, Moon KC, Kang HG, Ha IS, Cheong HI. Familial IPEX syndrome: different glomerulopathy in two siblings. <span><span class="ref-journal">Pediatr Int. </span>2015;<span class="ref-vol">57</span>:e59–61.</span> [<a href="/pubmed/25712815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25712815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.powell.1982.731">Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. <span><span class="ref-journal">J Pediatr. </span>1982;<span class="ref-vol">100</span>:731–7.</span> [<a href="/pubmed/7040622" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7040622</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.rae.2015.284">Rae W, Gao Y, Bunyan D, Holden S, Gilmour K, Patel S, Wellesley D, Williams A. A novel FOXP3 mutation causing fetal alcinesia and recurrent male miscarriages. <span><span class="ref-journal">Clin Immunol. </span>2015;<span class="ref-vol">161</span>:284–5.</span> [<a href="/pubmed/26387632" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26387632</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.rao.2007.383">Rao A, Kamani N, Filipovich A, Lee SM, Davies SM, Dalal J, Shenoy S. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">109</span>:383–5.</span> [<a href="/pubmed/16990602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16990602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.reichert.2016.226">Reichert SL, McKay EM, Moldenhauer JS. Identification of a novel nonsense mutation in the FOXP3 gene in a fetus with hydrops-expanding the phenotype of IPEX syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170A</span>:226–32.</span> [<a href="/pubmed/26395338" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26395338</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.roifman.2000.6">Roifman CM. Human IL-2 receptor alpha chain deficiency. <span><span class="ref-journal">Pediatr Res. </span>2000;<span class="ref-vol">48</span>:6–11.</span> [<a href="/pubmed/10879793" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10879793</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.rubiocabezas.2009.111">Rubio-Cabezas O, Minton JA, Caswell R, Shield JP, Deiss D, Sumnik Z, Cayssials A, Herr M, Loew A, Lewis V, Ellard S, Hattersley AT. Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. <span><span class="ref-journal">Diabetes Care. </span>2009;<span class="ref-vol">32</span>:111–6.</span> [<a href="/pmc/articles/PMC2606841/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2606841</span></a>] [<a href="/pubmed/18931102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18931102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.ruemmele.2004.587">Ruemmele FM, Brousse N, Goulet O. Autoimmune enteropathy: molecular concepts. <span><span class="ref-journal">Curr Opin Gastroenterol. </span>2004;<span class="ref-vol">20</span>:587–91.</span> [<a href="/pubmed/15703687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15703687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.sakaguchi.2003.1310">Sakaguchi S. The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. <span><span class="ref-journal">J Clin Invest. </span>2003;<span class="ref-vol">112</span>:1310–2.</span> [<a href="/pmc/articles/PMC228490/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC228490</span></a>] [<a href="/pubmed/14597756" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14597756</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.scaillon.2009.368">Scaillon M, Van Biervliet S, Bontems P, Dorchy H, Hanssens L, Ferster A, Segers V, Cadranel S. Severe gastritis in an insulin-dependent child with an IPEX syndrome. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2009;<span class="ref-vol">49</span>:368–70.</span> [<a href="/pubmed/19633572" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19633572</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.seidel.2016.6">Seidel MG, Boztug K, Haas OA. Immune dysregulation syndromes (IPEX, CD27 deficiency, and others): always doomed from the start? <span><span class="ref-journal">J Clin Immunol. </span>2016;<span class="ref-vol">36</span>:6–7.</span> [<a href="/pubmed/26661331" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26661331</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.shehab.2017.1040">Shehab O, Tester DJ, Ackerman NC, Cowchock FS, Ackerman MJ. Whole genome sequencing identifies etiology of recurrent male intrauterine fetal death. <span><span class="ref-journal">Prenatal Diag. </span>2017;<span class="ref-vol">37</span>:1040–5.</span> [<a href="/pubmed/28833278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28833278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.sheikine.2015.1197">Sheikine Y, Woda CB, Lee PY, Chatila TA, Keles S, Charbonnier LM, Schmidt B, Rosen S, Rodig NM. Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder. <span><span class="ref-journal">Pediatr Nephrol. </span>2015;<span class="ref-vol">30</span>:1197–202.</span> [<a href="/pubmed/25911531" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25911531</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.sherman.2004.16">Sherman PM, Mitchell DJ, Cutz E. Neonatal enteropathies: defining the causes of protracted diarrhea of infancy. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2004;<span class="ref-vol">38</span>:16–26.</span> [<a href="/pubmed/14676590" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14676590</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.strauss.2007.320">Strauss L, Whiteside TL, Knights A, Bergmann C, Knuth A, Zippelius A. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. <span><span class="ref-journal">J Immunol. </span>2007;<span class="ref-vol">178</span>:320–9.</span> [<a href="/pubmed/17182569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17182569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.tommasini.2002.127">Tommasini A, Ferrari S, Moratto D, Badolato R, Boniotto M, Pirulli D, Notarangelo LD, Andolina M. X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. <span><span class="ref-journal">Clin Exp Immunol. </span>2002;<span class="ref-vol">130</span>:127–30.</span> [<a href="/pmc/articles/PMC1906506/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1906506</span></a>] [<a href="/pubmed/12296863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12296863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.torgerson.2007.1705">Torgerson TR, Linane A, Moes N, Anover S, Mateo V, Rieux-Laucat F, Hermine O, Vijay S, Gambineri E, Cerf-Bensussan N, Fischer A, Ochs HD, Goulet O, Ruemmele FM. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. <span><span class="ref-journal">Gastroenterology. </span>2007;<span class="ref-vol">132</span>:1705–17.</span> [<a href="/pubmed/17484868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17484868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.vasiljevic.2015.2120">Vasiljevic A, Poreau B, Bouvier R, Lachaux A, Arnoult C, Faure J, Cordier MP, Ray PF. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome and recurrent intrauterine fetal death. <span><span class="ref-journal">Lancet. </span>2015;<span class="ref-vol">385</span>:2120.</span> [<a href="/pubmed/26009232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26009232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.wildin.2002.537">Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:537–45.</span> [<a href="/pmc/articles/PMC1735203/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735203</span></a>] [<a href="/pubmed/12161590" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12161590</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.xavierdasilva.2015.131">Xavier-da-Silva MM, Moreira-Filho CA, Suzuki E, Patricio F, Coutinho A, Coutinho A, Carneiro-Sampaio M. Fetal-onset IPEX: Report of two families and review of literature. <span><span class="ref-journal">Clin Immunol. </span>2015;<span class="ref-vol">156</span>:131–40.</span> [<a href="/pubmed/25546394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25546394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.yong.2008.581">Yong PL, Russo P, Sullivan KE. Use of sirolimus in IPEX and IPEX-like children. <span><span class="ref-journal">J Clin Immunol. </span>2008;<span class="ref-vol">28</span>:581–7.</span> [<a href="/pubmed/18481161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18481161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ipex.REF.zhou.2008.236">Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubstov YP, Rudensky AY, Ziegler SF, Littman DR. TGF&#x003b2;-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing ROR&#x003b3;t function. <span><span class="ref-journal">Nature. </span>2008;<span class="ref-vol">453</span>:236–40.</span> [<a href="/pmc/articles/PMC2597437/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2597437</span></a>] [<a href="/pubmed/18368049" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18368049</span></a>]</div></li></ul></div></div><div id="ipex.Chapter_Notes"><h2 id="_ipex_Chapter_Notes_">Chapter Notes</h2><div id="ipex.Author_History"><h3>Author History</h3><p>Mark C Hannibal, MD, PhD; University of Michigan Medical School (2004-2018)</p><p>Raymond J Louie, PhD (2018-present)</p><p>John W Sleasman, MD (2018-present)</p><p>Queenie K-G Tan, MD, PhD (2018-present)</p><p>Troy Torgerson, MD, PhD; University of Washington, Seattle (2004-2018)</p></div><div id="ipex.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>19 July 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 January 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 December 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 April 2006 (cd) Revision: FOXP3 testing available clinically</div></li><li class="half_rhythm"><div>19 October 2004 (me) Review posted live</div></li><li class="half_rhythm"><div>11 February 2004 (mh) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1118</span><span class="label">PMID: <a href="/pubmed/20301297" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301297</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/insr-ir/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/vws/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1118&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1118/?report=reader">PubReader</a></li><li><a href="/books/NBK1118/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1118" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1118" style="display:none" title="Cite this Page"><div class="bk_tt">Tan QKG, Louie RJ, Sleasman JW. IPEX Syndrome. 2004 Oct 19 [Updated 2018 Jul 19]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1118/pdf/Bookshelf_NBK1118.pdf">PDF version of this page</a> (508K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ipex.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ipex.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ipex.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ipex.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ipex.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ipex.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ipex.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ipex.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ipex.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ipex.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ipex.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=50943[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FOXP3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1489498" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1489498" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1489498" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1489498" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301584" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Allenspach E, Rawlings DJ, Scharenberg AM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25299040" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Barth Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Barth Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ferreira C, Thompson R, Vernon H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301357" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAS</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAS</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chandra S, Bronicki L, Nagaraj CB, Zhang K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301769" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clinton C, Gazda HT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301287" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autoimmune Lymphoproliferative Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autoimmune Lymphoproliferative Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bleesing JJH, Nagaraj CB, Zhang K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301297" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301297" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0410ccdd21425a25986055">IPEX Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">IPEX Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:45:48-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CD11AE0401721000000000653022F&amp;ncbi_session=CE8CD11AE0410CC1_1619SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1118%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1118&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1118/&amp;ncbi_pagename=IPEX Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CD11AE0410CC1_1619SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>